Latest News about Michael Mullette
Recent news which mentions Michael Mullette
Shake Up At Lykos Therapeutics After FDA Blocks Ecstasy-Based Treatment, CEO Steps Down
September 05, 2024
From Benzinga
Former Moderna Vice President Joins Psychedelics Company In Phase 3 Trials For Ecstasy
March 08, 2022
Tickers
MAPS
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>